KYN-101

• Description :

  KYN-101 is an orally active and selective aryl hydrocarbon receptor (AHR) inhibitor with anticancer activity. KYN-101 decreases CYP1A1 mRNA expression and can be used in the study of breast cancer and acute myeloid leukemia. KYN-101 is an orally active and selective aryl hydrocarbon receptor (AHR) inhibitor with anticancer activity.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  386.43

• Molecular Formula :

  C22H19FN6

• Notes :

  Research use only, not for human use.

• Receptor :

  AhR

• CAS Number :

  2247950-73-6